These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2227128

  • 1. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T, Mølvig J, Andersen HU, Helqvist S, Spinas GA, Munck M.
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [Abstract] [Full Text] [Related]

  • 2. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
    Petersen JS, Dyrberg T, Karlsen AE, Mølvig J, Michelsen B, Nerup J, Mandrup-Poulsen T.
    Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
    [Abstract] [Full Text] [Related]

  • 3. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
    Mandrup-Poulsen TR, Mølvig JC, Andersen V, Bendtzen K, Binder C, Brøns M, d'Amore FA, Dieperink H, Enk B, Frandsen NE.
    Ugeskr Laeger; 1990 Jul 02; 152(27):1963-9. PubMed ID: 2195734
    [Abstract] [Full Text] [Related]

  • 4. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics.
    Mandrup-Poulsen T, Nerup J, Stiller CR, Marner B, Bille G, Heinrichs D, Martell R, Dupre J, Keown PA, Jenner MR.
    Lancet; 1985 Mar 16; 1(8429):599-602. PubMed ID: 2857945
    [Abstract] [Full Text] [Related]

  • 5. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF.
    Diabetes; 1988 Jan 16; 37(1):99-103. PubMed ID: 3275559
    [Abstract] [Full Text] [Related]

  • 6. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S, Pawlowski B, Greulich B, Ziegler AG, Mandrup-Poulsen T, Mahon J.
    Diabetes Care; 1992 Jan 16; 15(1):66-74. PubMed ID: 1737543
    [Abstract] [Full Text] [Related]

  • 7. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M, Karjalainen J, Akerblom HK.
    Diabetes Care; 1998 Oct 16; 21(10):1670-3. PubMed ID: 9773728
    [Abstract] [Full Text] [Related]

  • 8. Immunogenetic heterogeneity in type I (insulin-dependent) diabetes among the Tunisian population. HLA-DR antigens and organ-specific autoantibodies (family study).
    Jenhani F, Bardi R, Chammakhi S, Jeddi M, Ayed K.
    J Autoimmun; 1991 Jun 16; 4(3):553-61. PubMed ID: 1910427
    [Abstract] [Full Text] [Related]

  • 9. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec 16; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of insulin release in vitro mediated by mononuclear cells from diabetic patients treated with cyclosporin A or placebo.
    Debray-Sachs M, Sai P, Feutren G, Lang F, Maugendre D, Boitard C, Hors J, Bach JF.
    Diabetes; 1988 Jul 16; 37(7):873-7. PubMed ID: 3290005
    [Abstract] [Full Text] [Related]

  • 11. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C, Allendörfer J, Hatziagelaki E, Dyrberg T, Bergis KH, Federlin K, Bretzel RG.
    Horm Metab Res; 1997 Oct 16; 29(10):510-5. PubMed ID: 9405979
    [Abstract] [Full Text] [Related]

  • 12. Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12-mo follow-up of an Italian population.
    Pagano G, Cavallo-Perin P, Cavalot F, Dall'Omo AM, Masciola P, Suriani R, Amoroso A, Curtoni SE, Borelli I, Lenti G.
    Diabetes; 1987 Jul 16; 36(7):859-63. PubMed ID: 3556283
    [Abstract] [Full Text] [Related]

  • 13. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M, Gomis R, Ercilla G, Casamitjana R, Bottazzo GF, Pujol-Borrell R.
    Diabetes; 1989 Nov 16; 38(11):1396-401. PubMed ID: 2695374
    [Abstract] [Full Text] [Related]

  • 14. Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation.
    Bosi E, Bottazzo GF, Secchi A, Pozza G, Shattock M, Saunders A, Gelet A, Touraine JL, Traeger J, Dubernard JM.
    Diabetes; 1989 Jan 16; 38 Suppl 1():82-4. PubMed ID: 2642861
    [Abstract] [Full Text] [Related]

  • 15. Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.
    Snorgaard O, Hartling SG, Binder C.
    Diabetologia; 1990 Jan 16; 33(1):36-42. PubMed ID: 2303172
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
    Diabetes; 1988 Nov 16; 37(11):1574-82. PubMed ID: 2903105
    [Abstract] [Full Text] [Related]

  • 17. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
    Kobayashi T, Sugimoto T, Itoh T, Kosaka K, Tanaka T, Suwa S, Sato K, Tsuji K.
    Diabetes; 1986 Mar 16; 35(3):335-40. PubMed ID: 3512344
    [Abstract] [Full Text] [Related]

  • 18. Genetic epidemiology of persistent islet cell antibodies among IDDM patients.
    Newman B, Selby J, Lee M, King MC.
    Genet Epidemiol; 1989 Mar 16; 6(1):123-6. PubMed ID: 2659427
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B, Michaelis D, Hildmann W, Richter KV, Kohnert KD.
    Diabetes Res; 1987 Feb 16; 4(2):73-7. PubMed ID: 3034475
    [Abstract] [Full Text] [Related]

  • 20. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
    Bougnères PF, Landais P, Boisson C, Carel JC, Frament N, Boitard C, Chaussain JL, Bach JF.
    Diabetes; 1990 Oct 16; 39(10):1264-72. PubMed ID: 2210078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.